Dyne Therapeutics Inc (DYN) — Cash Flow Reinvestment Rate
Dyne Therapeutics Inc (DYN) has a Cash Flow Reinvestment Rate of 2.73x as of December 2017, reinvesting $229.00 Million (capex $224.00 Million plus investments $5.00 Million) from operating cash flow of $84.00 Million. Explore Dyne Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dyne Therapeutics Inc Cash Flow Reinvestment Rate (2007–2017)
Historical reinvestment intensity for Dyne Therapeutics Inc across 8 annual periods. Also explore DYN current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Dyne Therapeutics Inc (2007–2017)
Year-by-year capital reinvestment analysis for Dyne Therapeutics Inc. For live market cap and broader valuation context, see DYN stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.38x | $224.00 Million | $585.00 Million | $224.00 Million | ▼ -20.6% |
| 2016 | 0.48x | $326.00 Million | $676.00 Million | $326.00 Million | ▼ -83.5% |
| 2015 | 2.93x | $275.00 Million | $94.00 Million | $275.00 Million | ▲ +422.4% |
| 2013 | 0.56x | $98.00 Million | $175.00 Million | $98.00 Million | ▼ -28.9% |
| 2010 | 0.79x | $333.00 Million | $423.00 Million | $333.00 Million | — |
| 2009 | 0.00x | $0.00 | $135.00 Million | $0.00 | — |
| 2008 | 0.00x | $0.00 | $319.00 Million | $0.00 | — |
| 2007 | 0.00x | $0.00 | $341.00 Million | $0.00 | — |